Feedback / Questions
PNT2002 - POINT Biopharma, Lantheus
rosopatamab-225Ac (CONV01-α) - Weill Cornell Medical College, Dominari Holdings
http://clinicaltrials.gov/ct2/show/NCT04886986
Aug 1, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next